These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis. Luo L; Huang W; Ren F; Zhou J; Huang D; Tang L Rheumatology (Oxford); 2021 Apr; 60(4):e132-e133. PubMed ID: 33197245 [No Abstract] [Full Text] [Related]
7. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies. Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801 [No Abstract] [Full Text] [Related]
8. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. Kurtzman DJB; Vleugels RA J Am Acad Dermatol; 2018 Apr; 78(4):776-785. PubMed ID: 29229575 [TBL] [Abstract][Full Text] [Related]
9. Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease. Fujimoto N; Honda S; Wakabayashi M; Hamaguchi Y; Fujimoto M; Tanaka T Mod Rheumatol; 2016 Jul; 26(4):614-6. PubMed ID: 24842478 [TBL] [Abstract][Full Text] [Related]
10. Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis. Zhang SH; Zhao Y; Xie QB; Jiang Y; Wu YK; Yan B Br J Dermatol; 2019 May; 180(5):1090-1098. PubMed ID: 29947075 [TBL] [Abstract][Full Text] [Related]
11. Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody. Kishida D; Ushiyama S; Shimojima Y; Ueno KI; Kurashina JI; Shirai T; Sekijima Y Intern Med; 2021 Aug; 60(16):2697-2700. PubMed ID: 33678748 [TBL] [Abstract][Full Text] [Related]
12. Myxovirus resistance protein 1-expressing fatal myocarditis in a patient with anti-MDA5 antibody-positive dermatomyositis. Sakamoto R; Kotobuki Y; Iga S; Nojima S; Deno R; Hanaoka Y; Tonomura K; Kiyohara E; Nakagawa Y; Ueda-Hayakawa I; Arase N; Fujimoto M Rheumatology (Oxford); 2021 Dec; 60(12):e450-e452. PubMed ID: 34382080 [No Abstract] [Full Text] [Related]
13. Anti-MDA-5-positive amyopathic dermatomyositis with cutaneous ulcerations. Chen Y; Teng GG; Teo WZ Med J Aust; 2021 Jul; 215(1):21-21.e1. PubMed ID: 34028032 [No Abstract] [Full Text] [Related]
14. MDA5 Cassius C; Amode R; Delord M; Battistella M; Poirot J; How-Kit A; Lepelletier C; Jachiet M; de Masson A; Frumholtz L; Cordoliani F; Boccara D; Lehmann-Che J; Wong J; Dubanchet S; Alberdi AJ; Merandet M; Bagot M; Bensussan A; Bouaziz JD; Le Buanec H J Invest Dermatol; 2020 Jun; 140(6):1276-1279.e7. PubMed ID: 31955963 [No Abstract] [Full Text] [Related]
15. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium. Figueiredo C; Matos AL; Calvao J; Goncalo M Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870 [No Abstract] [Full Text] [Related]
16. Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases. Barrientos N; Sicilia JJ; Moreno de Vega MJ; Dominguez JD Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):188-190. PubMed ID: 29162227 [No Abstract] [Full Text] [Related]
20. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease. Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]